<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>International Federation of Gynecology and Obstetrics (FIGO) staging of cancer of the cervix uteri (2018; corrigendum 2019)</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">International Federation of Gynecology and Obstetrics (FIGO) staging of cancer of the cervix uteri (2018; corrigendum 2019)</h1>
<div class="graphic"><div class="figure"><div class="ttl">International Federation of Gynecology and Obstetrics (FIGO) staging of cancer of the cervix uteri (2018; corrigendum 2019)</div><div class="cntnt"><table cellspacing="0"><colgroup width="10%"></colgroup> <colgroup width="90%"></colgroup> <tbody> <tr> <td class="subtitle1_left">Stage</td> <td class="subtitle1_left">Description</td> </tr> <tr> <td class="indent1">I</td> <td>The carcinoma is strictly confined to the cervix (extension to the uterine corpus should be disregarded)</td> </tr> <tr> <td class="indent2">IA</td> <td>Invasive carcinoma that can be diagnosed only by microscopy, with maximum depth of invasion &lt;5 mm*</td> </tr> <tr> <td class="indent3">IA1</td> <td>Measured stromal invasion ≤3 mm in depth</td> </tr> <tr> <td class="indent3">IA2</td> <td>Measured stromal invasion &gt;3 mm and ≤5 mm in depth</td> </tr> <tr> <td class="indent2">IB</td> <td>Invasive carcinoma with measured deepest invasion &gt;5 mm (greater than Stage IA), lesion limited to the cervix uteri<sup>¶</sup></td> </tr> <tr> <td class="indent3">IB1</td> <td>Invasive carcinoma &gt;5 mm depth of stromal invasion, and ≤2 cm in greatest dimension</td> </tr> <tr> <td class="indent3">IB2</td> <td>Invasive carcinoma &gt;2 cm and ≤4 cm in greatest dimension</td> </tr> <tr> <td class="indent3">IB3</td> <td>Invasive carcinoma &gt;4 cm in greatest dimension</td> </tr> <tr> <td class="indent1">II</td> <td>The carcinoma invades beyond the uterus, but has not extended onto the lower third of the vagina or to the pelvic wall</td> </tr> <tr> <td class="indent2">IIA</td> <td>Involvement limited to the upper two-thirds of the vagina without parametrial involvement</td> </tr> <tr> <td class="indent3">IIA1</td> <td>Invasive carcinoma ≤4 cm in greatest dimension</td> </tr> <tr> <td class="indent3">IIA2</td> <td>Invasive carcinoma &gt;4 cm in greatest dimension</td> </tr> <tr> <td class="indent2">IIB</td> <td>With parametrial involvement but not up to the pelvic wall</td> </tr> <tr> <td class="indent1">III</td> <td>The carcinoma involves the lower third of the vagina and/or extends to the pelvic wall and/or causes hydronephrosis or nonfunctioning kidney and/or involves pelvic and/or paraaortic lymph nodes<sup>Δ</sup></td> </tr> <tr> <td class="indent2">IIIA</td> <td>The carcinoma involves the lower third of the vagina, with no extension to the pelvic wall</td> </tr> <tr> <td class="indent2">IIIB</td> <td>Extension to the pelvic wall and/or hydronephrosis or nonfunctioning kidney (unless known to be due to another cause)</td> </tr> <tr> <td class="indent2">IIIC</td> <td>Involvement of pelvic and/or paraaortic lymph nodes (including micrometastases), irrespective of tumor size and extent (with r and p notations)<sup>Δ</sup></td> </tr> <tr> <td class="indent3">IIIC1</td> <td>Pelvic lymph node metastasis only</td> </tr> <tr> <td class="indent3">IIIC2</td> <td>Paraaortic lymph node metastasis</td> </tr> <tr> <td class="indent1">IV</td> <td>The carcinoma has extended beyond the true pelvis or has involved (biopsy proven) the mucosa of the bladder or rectum. (A bullous edema, as such, does not permit a case to be allotted to Stage IV.)</td> </tr> <tr> <td class="indent2">IVA</td> <td>Spread to adjacent pelvic organs</td> </tr> <tr> <td class="indent2">IVB</td> <td>Spread to distant organs</td> </tr> </tbody></table></div><div class="graphic_lgnd">When in doubt, the lower staging should be assigned.</div><div class="graphic_footnotes"><p>* Imaging and pathology can be used, where available, to supplement clinical findings with respect to tumor size and extent, in all stages.</p>
<p>¶ The involvement of vascular/lymphatic spaces does not change the staging. The lateral extent of the lesion is no longer considered.</p>
Δ Adding notation of r (imaging) and p (pathology) to indicate the findings that are used to allocate the case to Stage IIIC. Example: If imaging indicates pelvic lymph node metastasis, the stage allocation would be Stage IIIC1r, and if confirmed by pathologic findings, it would be Stage IIIC1p. The type of imaging modality or pathology technique used should always be documented.</div><div class="graphic_reference"><p>From: Bhatla N, Aoki D, Sharma DN, Sankaranarayanan R. Cancer of the cervix uteri. Int J Gynaecol Obstet 2018; 143 S2:22. Available at: <a href="https://obgyn.onlinelibrary.wiley.com/doi/full/10.1002/ijgo.12611" target="_blank">https://obgyn.onlinelibrary.wiley.com/doi/full/10.1002/ijgo.12611</a>. Reproduced under the terms of the <a href="https://creativecommons.org/licenses/by/4.0/" target="_blank">Creative Commons License 4.0</a>.</p>
Updated with information from: Corrigendum to "Revised FIGO Staging for Carcinoma of the Cervix Uteri." Int J Gynaecol Obstet 2019; 147:279.</div><div id="graphicVersion">Graphic 119447 Version 4.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
